BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3259681)

  • 1. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. II. Lymphocyte subpopulations.
    Balaram P; Padmanabhan TK; Vasudevan DM
    Neoplasma; 1988; 35(2):235-42. PubMed ID: 3259681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer--immune responses.
    Balaram P; Remani P; Padmanabhan TK; Vasudevan DM
    Neoplasma; 1988; 35(6):617-25. PubMed ID: 3221935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. I. A three-year clinical follow up.
    Padmanabhan TK; Balaram P; Vasudevan DM
    Neoplasma; 1987; 34(5):627-32. PubMed ID: 3696303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
    Olkowski ZL; McLaren JR; Skeen MJ
    Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte populations in premalignant lesions and cancer of the oral cavity.
    Pillai MR; Balaram P; Abraham T; Nair MK
    Neoplasma; 1987; 34(4):469-79. PubMed ID: 3498910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levamisole versus placebo as an adjunct to primary therapy of laryngopharyngeal epidermoid carcinoma. Evaluation of the immune status.
    Mussche RA; Plum J; de Smedt M; Kluyskens P
    Acta Otorhinolaryngol Belg; 1977; 31(6):566-77. PubMed ID: 339662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative and functional response of a lymphatic subpopulation during adjuvant intermittent chemo-immunotherapy in breast cancer].
    Betzler M; Flad HD; Huget R; Schreml W; Schlag P; Herfarth C
    Chir Forum Exp Klin Forsch; 1978; (1978):227-30. PubMed ID: 313321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
    Pozsonyi T; Jakab L; Fehér J
    Allergol Immunopathol (Madr); 1980; 8(5):553-8. PubMed ID: 6970515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of E-rosette formation by levamisole and its abrogation by autochthonous serum from cattle with squamous cell carcinoma of horn.
    Dhingra VK; Gupta RK; Sadana JR
    Res Vet Sci; 1982 Sep; 33(2):142-5. PubMed ID: 6983096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte subsets in measles. Depressed helper/inducer subpopulation reversed by in vitro treatment with levamisole and ascorbic acid.
    Joffe MI; Sukha NR; Rabson AR
    J Clin Invest; 1983 Sep; 72(3):971-80. PubMed ID: 6604071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological status in patients of oral cancers. A clinico-pathological study.
    Sharma BD; Gupta CK; Elhence BR; Maurya SD; Gupta HC
    Indian J Cancer; 1983; 20(3):161-5. PubMed ID: 6606610
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy of gastrointestinal cancer patients with levamisole.
    Miwa H; Orita K
    Acta Med Okayama; 1979 Feb; 33(1):29-42. PubMed ID: 155980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy with levamisole in sepsis in newborn infants].
    Isakov IuF; Samsygin SA; Dolgina EN; Mortina SV
    Vestn Akad Med Nauk SSSR; 1983; (4):57-61. PubMed ID: 6603078
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of longterm administration of levamisole on total lymphocyte and T cell subsets in rheumatoid arthritis.
    Veys EM; Mielants H; Verbruggen G; Suykens S
    J Rheumatol; 1984 Jun; 11(3):398-400. PubMed ID: 6610760
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report.
    Rabin BS; Johnson J; Claassen D
    Laryngoscope; 1984 May; 94(5 Pt 1):688-90. PubMed ID: 6232437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [E-RFC (T cells) and Ig-positive cells (B cells) in the peripheral blood of patients with lymphogranulomatosis and possible immunocorrection with levamisole].
    Markova TP; Danilova NV
    Ter Arkh; 1985; 57(7):15-8. PubMed ID: 3876611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of lymphocytes and T-cell subsets in patients with disseminated cancer.
    Cobleigh MA; Braun DP; Harris JE
    J Natl Cancer Inst; 1980 May; 64(5):1041-5. PubMed ID: 6966003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunotherapy of breast cancer (review of foreign literature)].
    Liapis MA
    Vopr Onkol; 1983; 29(8):68-74. PubMed ID: 6351428
    [No Abstract]   [Full Text] [Related]  

  • 19. Developing an Immunotherapy Strategy for the Effective Treatment of Oral, Head and Neck Squamous Cell Carcinoma.
    Bell RB; Leidner R; Feng Z; Crittenden MR; Gough MJ; Fox BA
    J Oral Maxillofac Surg; 2015 Dec; 73(12 Suppl):S107-15. PubMed ID: 26608138
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunological status and therapeutic use of levamisole in autoimmune hemolytic anemia].
    Krylov AA; Maksimov AV
    Ter Arkh; 1983; 55(8):71-5. PubMed ID: 6605589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.